InvestorsHub Logo
Followers 21
Posts 2568
Boards Moderated 0
Alias Born 12/07/2013

Re: None

Wednesday, 09/21/2022 2:00:15 PM

Wednesday, September 21, 2022 2:00:15 PM

Post# of 429056
OH Yes !

First published: 19 September 2022 https://doi.org/10.1002/ctm2.895

Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: A single-blind randomized controlled trial

In conclusion, this proof-of-concept trial points to possible additive beneficial effects of n-3 PUFA treatment in COVID-19 on top of current treatment recommendations, in particular for vulnerable older COVID-19 patients with multiple comorbidities, which tolerated and responded to n-3 PUFA treatment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News